ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Vial Containment Systems For Gene And Cell Therapies

  CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.

• Meeting The Growing Demand For Pre-Filled Syringes

  The market for pre-filled syringes is growing rapidly. Learn more about the benefits for consumers, providers, and manufacturers, and the importance of partnering with a reliable fill finish facility.

• Considerations In Formulation Development Of Injectable Solutions

  Injectable solutions offer an alternative to oral dosage form due to fast onset, reproducible PK/efficacy profile, high bioavailability, and suitability of administration under hospital setting.

• Amorphous Formulations For Insoluble Drugs: Rational Design & Practical Approaches On Formulation Screening & Development

  The issues associated with amorphous formulations include solid state stability, chemical stability, reproducibility of API manufacturing, impurity of API, in vitro in vivo performance, process and scale-up.

• How A Flexible Approach To Autoinjector Assembly Can Be Advantageous

  Examine how a flexible, scalable, and efficient solution for the assembly of autoinjectors can help you stay ahead of the competition and meet the demands of an ever-changing industry.

• Partnership Goals For Scale-Up Success

  As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb.

• Improved Biomanufacturing Processes And Drug Product Stability

  Improve upstream media for bioavailability and foam stability, downstream buffers for purification, and the formulation and final fill drug product stability with this highly interdisciplinary process.

• How Recent Trends Impact Bringing Your Molecule To Market

  With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.

• Mitigating Particulate Risk In Injectables

  What are the sources of such particulates in injectables, and how should manufacturers apply the latest regulations to ensure best practice when producing sterile drug products?

• Streamline Early-Stage Development To Reach The Clinic Faster

  Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.